Cadungog, Shella Mae O.
HRN: 23-92-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/27/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/27/2024
02/02/2024
IV
1000mg
Q6h
T/c Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes